Studying the biological properties of pleural fluid: pleural fluid alone is adequate for cancer cell proliferation in vitro

R. Asciak (Oxford, United Kingdom), N. Kanellakis (Oxford, United Kingdom), X. Yao (Oxford, United Kingdom), M. Abd Hamid (Oxford, United Kingdom), T. Dong (Oxford, United Kingdom), R. Mercer (Oxford, United Kingdom), M. Hassan (Oxford, United Kingdom), E. Bedawi (Oxford, United Kingdom), M. Dobson (Oxford, United Kingdom), S. Montefort (Msida, Malta), P. Fsadni (Msida, Malta), N. Rahman (Oxford, United Kingdom), I. Psallidas (Oxford, United Kingdom)

Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Disease area: Thoracic oncology

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Asciak (Oxford, United Kingdom), N. Kanellakis (Oxford, United Kingdom), X. Yao (Oxford, United Kingdom), M. Abd Hamid (Oxford, United Kingdom), T. Dong (Oxford, United Kingdom), R. Mercer (Oxford, United Kingdom), M. Hassan (Oxford, United Kingdom), E. Bedawi (Oxford, United Kingdom), M. Dobson (Oxford, United Kingdom), S. Montefort (Msida, Malta), P. Fsadni (Msida, Malta), N. Rahman (Oxford, United Kingdom), I. Psallidas (Oxford, United Kingdom). Studying the biological properties of pleural fluid: pleural fluid alone is adequate for cancer cell proliferation in vitro. 4494

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM)
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017


Early pleural fluid control is warranted to prevent reaccumulation of malignant pleural effusion in oncogene-driven lung cancer
Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding
Year: 2019




Is it important to determine pleural fluid amylase in patients with malignant pleural effusions?
Source: Eur Respir J 2007; 30: Suppl. 51, 565s
Year: 2007

Proliferation controlling intercellular signalling pathways in human pleural malignant mesothelioma
Source: Annual Congress 2007 - Pleural malignancy
Year: 2007



Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010


Biological characteristics of dendritic cells from malignant pleural effusions in patients with lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 772s
Year: 2006

The effect of pleural fluid content to the development of pleural thickness
Source: Eur Respir J 2002; 20: Suppl. 38, 548s
Year: 2002

Could microsatellite analysis of pleural fluid increase sensitivity of pleural fluid cytology?
Source: Annual Congress 2007 - Novel genetic markers in pathology
Year: 2007


Malignant pleural effusion cells show aberrant glucose metabolism gene expression
Source: Eur Respir J 2011; 37: 1453-1465
Year: 2011



Serum and pleural fluid cytokines in pleural tuberculosis with and without lung parenchyma involvement
Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions
Year: 2011


Pleural fluid DNA integrity index as a diagnostic marker of malignant pleural effusion
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017

Assessing the role of pleural fluid in current cancer diagnostic pathway.
Source: Virtual Congress 2020 – Management issues in thoracic oncology
Year: 2020


Effect of sampling phase of pleural fluid on the abundance of malignant cells in cytologic smears of effusions due to adenocarcinoma
Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools
Year: 2009



LSC Abstract – A requirement for mast cells in malignant pleural effusion
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015

Polarized cytokine profiles in the peripheral blood and pleural fluid from the patients with tuberculous pleurisy, pulmonary tuberculosis combined disease, and malignant pleural effusion
Source: Eur Respir J 2004; 24: Suppl. 48, 467s
Year: 2004

Novel Synthetic lignan reduces asbestos-induced damage in human pleural mesothelial cells-Potential clinical usefulness in inhibiting pleural malignant mesothelioma
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017


Impaired expression of telomerase activity in bronchoalveolar lavage fluid cells in patients with lung cancer: Preliminary results
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010

Investigation of genetic alterations in malignant and infectious pleural fluid: preliminary results
Source: Eur Respir J 2006; 28: Suppl. 50, 811s
Year: 2006

Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010

Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009